These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16159966)

  • 41. Wall stress determines systolic and diastolic function--Characteristics of heart failure.
    Alter P; Koczulla AR; Nell C; Figiel JH; Vogelmeier CF; Rominger MB
    Int J Cardiol; 2016 Jan; 202():685-93. PubMed ID: 26454537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from 'PREDICTOR', a population based-study in central Italy.
    Mureddu GF; Tarantini L; Agabiti N; Faggiano P; Masson S; Latini R; Cesaroni G; Miceli M; Forastiere F; Scardovi AB; Uguccioni M; Boccanelli A
    Eur J Heart Fail; 2013 Oct; 15(10):1102-12. PubMed ID: 23787717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subtle systolic dysfunction may be associated with the tendency to develop diastolic heart failure in patients with preserved left ventricular ejection fraction.
    Sürücü H; Tatli E; Değirmenci A; Okudan S; Boz H
    Echocardiography; 2009 Apr; 26(4):365-70. PubMed ID: 19382943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic role of exercise echocardiography in heart failure.
    Rubiś P; Drabik L; Kopeć G; Olszowska M; Płazak W; Podolec P
    Kardiol Pol; 2011; 69(7):656-63. PubMed ID: 21769781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
    Catuzzo B; Ciancamerla F; Bobbio M; Longo M; Trevi GP
    J Card Fail; 2003 Aug; 9(4):303-10. PubMed ID: 13680551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of plasma brain natriuretic peptide measurement and tissue Doppler imaging in identifying isolated left ventricular diastolic dysfunction without heart failure.
    Goto T; Ohte N; Wakami K; Asada K; Fukuta H; Mukai S; Tani T; Kimura G
    Am J Cardiol; 2010 Jul; 106(1):87-91. PubMed ID: 20609653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.
    Kim H; Jun DW; Cho YK; Nam CW; Han SW; Hur SH; Kim YN; Kim KB
    Echocardiography; 2008 Oct; 25(9):961-7. PubMed ID: 18771554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction.
    Morris DA; Boldt LH; Eichstädt H; Ozcelik C; Haverkamp W
    Circ Heart Fail; 2012 Sep; 5(5):610-20. PubMed ID: 22874137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload.
    Mottram PM; Haluska BA; Marwick TH
    Am Heart J; 2004 Aug; 148(2):365-70. PubMed ID: 15309010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide.
    Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y
    J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systolic dysfunction in heart failure with a normal ejection fraction: echo-Doppler measurements.
    Sanderson JE; Fraser AG
    Prog Cardiovasc Dis; 2006; 49(3):196-206. PubMed ID: 17084179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.
    Betti I; Castelli G; Barchielli A; Beligni C; Boscherini V; De Luca L; Messeri G; Gheorghiade M; Maisel A; Zuppiroli A
    J Card Fail; 2009 Jun; 15(5):377-84. PubMed ID: 19477397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction.
    Murtagh G; Dawkins IR; O'Connell R; Badabhagni M; Patel A; Tallon E; O'Hanlon R; Ledwidge MT; McDonald KM
    Eur J Heart Fail; 2012 May; 14(5):480-6. PubMed ID: 22416086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.